studies using cationic probes have suggested that a reduction in glomerular anionic sites , composed principally of the glycosaminoglycan heparan sulphate , is responsible for the abnormal glomerular permeability in the congenital nephrotic syndrome ( cns ) .
C0017973
glycosaminoglycan
C0019143
heparan sulphate